Emergency kits recalled | FDA investigating LAAO outcomes | Next-day discharge after TAVR

The company warned customers that these kits may no longer be an effective treatment for severe low blood sugar. 

Recent research published in JAMA Cardiology caught the agency's attention.

Researchers shared their findings at the European Association for the Study of Diabetes (EASD) 2021 Annual Meeting.

Researchers tracked data from six different studies, focusing on the likelihood of potential issues such as bleeding and vascular complications.

Meanwhile, patients are not exactly eager to monitor their blood pressure for 24 hours using a medical device. 

Gainesville's vaccine mandate for city employees appears to be dead in the water. 

Facilities with dedicated shock teams delivered shorter lengths of stay and a lower mortality rate. 

Researchers examined data from more than 3,000 TAVR procedures performed with balloon-expandable valves. 

The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included more than 20,000 patient encounters.

Many MRI-detected infarcts involved multiple vascular territories.

Advocates say payers' push for single first-line imaging tests for all patients isn't backed by evidence and may cause harm.